The Quiet Symptoms of M. Genitalium

What are the symptoms of M. genitalium?

Mycoplasma genitalium (M. genitalium, sometimes shortened to M. gen) is a bacterium that can infect the urethra and cervix, and its most common feature is producing no symptoms at all. When symptoms do appear, they overlap heavily with other causes of urethritis and cervicitis rather than presenting anything distinctive of their own — which is exactly why M. genitalium tends to surface as a diagnosis only after a more common cause has already been ruled out or treated without success.

There is no symptom pattern unique to M. genitalium — everything it causes can also be caused by chlamydia, gonorrhea, or trichomoniasis, so a lab test is the only way to know which organism is actually present. Trichomoniasis is a useful comparison: it is also a common, curable infection where most people who have it show no symptoms at all, and where the ones who do have symptoms describe a picture — discharge, irritation — that overlaps with several other causes 1Ref 1Centers for Disease Control and Prevention (2024).About Trichomoniasis.Supports that trichomoniasis is a common, curable STI where the majority of infected people have no symptoms, used here as a comparison for how M. genitalium's mostly-silent, overlapping symptom picture is not unusual among genital infections.. That overlap is the central fact to understand before reading through the symptom lists below.

Symptoms in men — nongonococcal urethritis

In men, M. genitalium is one of several causes of nongonococcal urethritis (NGU) — inflammation of the urethra not caused by gonorrhea. Ngu causes and treatment covers this presentation in more depth, but the core symptoms are burning or pain during urination and a discharge from the penis that can range from clear and watery to white or yellowish.

Some men with M. genitalium have mild, easy-to-dismiss irritation rather than a clear urethritis picture, and some have no symptoms whatsoever. Because gonorrhea and chlamydia cause a nearly identical presentation and are tested for far more routinely, M. genitalium is usually not the first explanation considered — it becomes relevant when symptoms persist after those two have been ruled out or treated.

Discharge that is mild or intermittent is easy to dismiss, especially if it does not interfere with daily life. Because M. genitalium can persist quietly for a long time when it does not resolve on its own, ongoing mild irritation is worth mentioning at a follow-up visit rather than waiting for it to become more obviously symptomatic.

Symptoms in women — cervicitis and beyond

In women, M. genitalium can cause cervicitis: abnormal vaginal discharge, burning during urination, pain during sex, or spotting or bleeding between periods or after sex. As in men, many infections cause no symptoms at all, which means the infection can persist unnoticed for a long time.

Less commonly, an untreated infection is associated with pelvic inflammatory disease (PID), the same downstream complication linked to untreated chlamydia and gonorrhea — pelvic or lower abdominal pain, along with the cervicitis symptoms above, is a reason to be evaluated rather than wait. M. genitalium's role in PID and in fertility outcomes is less firmly established than for chlamydia and gonorrhea, but it is taken seriously enough that persistent symptoms after standard treatment prompt clinicians to consider it.

Because bleeding between periods and pain during sex both have many other possible causes, it is easy to attribute either one to something else — a missed pill, ordinary cramping — and not connect it to an underlying infection. A pattern that persists across more than one cycle, rather than a single unusual month, is generally what prompts a closer look.

Why M. genitalium isn't part of routine testing

Unlike chlamydia and gonorrhea, M. genitalium testing is not recommended as part of an initial workup for urethritis or cervicitis. Current guidance reserves testing for cases where symptoms persist or recur after a person has already been treated empirically for the more common causes 2Ref 2Centers for Disease Control and Prevention (2021).Mycoplasma genitalium - STI Treatment Guidelines.Supports that M. genitalium testing is not recommended for an initial cervicitis/urethritis workup but is considered for persistent symptoms after empiric treatment.. That sequencing is deliberate, not an oversight — M. genitalium is harder to test for at scale, and treating it presumptively alongside chlamydia and gonorrhea in every case of urethritis is not how the guideline recommends managing it.

The comprehensive national guidelines that cover chlamydia, gonorrhea, syphilis, trichomoniasis, and other STIs address M. genitalium within that same broader framework of diagnosing and managing genital symptoms 3Ref 3Workowski KA, Bachmann LH, Chan PA, et al. (Centers for Disease Control and Prevention) (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.The comprehensive U.S. evidence-based diagnostic and treatment recommendations covering chlamydia, gonorrhea, syphilis, trichomoniasis, PID, and other STIs including M. genitalium, used here to place M. genitalium within the broader diagnostic framework for genital symptoms., which is part of why M. genitalium usually enters the conversation only after those better-known infections have already been addressed.

What actually confirms M. genitalium

A specific nucleic acid amplification test (NAAT) is needed to detect M. genitalium — it does not appear on the tests routinely used for chlamydia, gonorrhea, or trichomoniasis, and it will not grow on a routine bacterial culture the way most bacteria will. The mycoplasma genitalium test window and exactly which sample type is used varies somewhat by lab, which is part of why this is a targeted test ordered for a specific reason rather than a routine screening item.

A clinician evaluating persistent urethritis or cervicitis after standard treatment has already failed is the most common reason this specific test gets ordered. Bringing up M. genitalium by name during that follow-up conversation, if it has not been raised already, is a reasonable thing to do.

What to do next

Most cases of M. genitalium respond well to treatment once identified, and having no symptoms does not mean the infection is more serious — it just means it can go unnoticed longer. The most useful next step for anyone with ongoing urethritis or cervicitis symptoms after a first round of treatment is asking directly whether M. genitalium testing makes sense, rather than assuming the first treatment simply needs more time.

Mycoplasma genitalium treatment is its own topic worth reading once a diagnosis is confirmed, since the approach depends on whether the specific strain is resistant to the first-choice antibiotic — a detail that shapes how the infection is managed differently from chlamydia or gonorrhea.